Anna Majowicz

Therapeutic hFIX Activity Achieved after Single AAV5-hFIX Treatment in Hemophilia B Patients and NHPs with Pre-existing Anti-AAV5 NABs

Anna Majowicz, Bart Nijmeijer, Margit H. Lampen et al. · Molecular Therapy — Methods & Clinical Development · 2019 · 120 citations · Full text

Hemophilia B Patients, Aav5-human Fix, Autoimmune Disease +12

Successful Repeated Hepatic Gene Delivery in Mice and Non-human Primates Achieved by Sequential Administration of AAV5 ch and AAV1

Anna Majowicz, David Salas, Nerea Zabaleta et al. · Molecular Therapy · 2017 · 73 citations · Full text

Mir‐142‐3p target sequences reduce transgene‐directed immunogenicity following intramuscular adeno‐associated virus 1 vector‐mediated gene delivery

Anna Majowicz, Piotr Maczuga, Karin L. Kwikkers et al. · The Journal of Gene Medicine · 2013 · 64 citations

Pre-existing humoral immunity and complement pathway contribute to immunogenicity of adeno-associated virus (AAV) vector in human blood

Corinne J. Smith, Nikki L. Ross, Ali Kamal et al. · Frontiers in Immunology · 2022 · 64 citations · Full text

Adaptive Immune System, Cellular Immunology, Viral Pathogenesis +25

Murine CD4+CD25- cells activated in vitro with PMA/ionomycin and anti-CD3 acquire regulatory function and ameliorate experimental colitis in vivo

Anna Majowicz, Sander van der Marel, Anje A. te Velde et al. · BMC Gastroenterology · 2012 · 12 citations · Full text